|Articles|July 1, 2006

Pharmacy Times

  • Volume 0
  • 0

RISING MEDICAID COSTS PEGGED TO ANTIDEPRESSANT Rxs

A sharp increase in prescriptions forpricey antidepressant drugs is driving upthe cost of the Medicaid drug program atan alarming rate, said researchers at theAgency for Healthcare Research andQuality.

In the 5 years from 1997 to 2002, thecost of Medicaid drugs more than doubledfrom $11.6 billion to $23.7 billion.Overall spending on Medicaid outpatientdrugs increased by 20% a year, theresearchers reported. A key factor in thatincrease is that the number of Medicaidbeneficiaries taking antidepressantsclimbed by 50% during the course of the5-year study, while spending for thesemedications shot up by 130%.

The investigators also found thatincreasing rates of prescribing forcyclooxygenase-2 inhibitors, protonpump inhibitors, and cholesterol-loweringmedications are driving up Medicaidcosts.

Articles in this issue

over 19 years ago

Hypertension

over 19 years ago

rx PRODUCTs

over 19 years ago

OTC Products

over 19 years ago

health-systems PRODUCT news

over 19 years ago

can you READ these Rxs?

over 19 years ago

compounding HOTLINE

over 19 years ago

Compounded Treatments for Migraines

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME